159 related articles for article (PubMed ID: 16261201)
1. [Preliminary study on nasal spray of interferon alpha-2b used for prevention of rubella and measles virus infections].
Zhao J; Zhu FC; Shu YL; Zhou R; Liu LQ; Zhang LL; Shi ZY; Tang Z; Lin LZ; Yu ZA; Zhang LP; Zhang B; Hou YD
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Sep; 19(3):220-2. PubMed ID: 16261201
[TBL] [Abstract][Full Text] [Related]
2. Waning antibodies in measles and rubella vaccinees--a longitudinal study.
Kremer JR; Schneider F; Muller CP
Vaccine; 2006 Mar; 24(14):2594-601. PubMed ID: 16427163
[TBL] [Abstract][Full Text] [Related]
3. [The clinico-immunological evaluation of a bivalent vaccine against measles and rubella].
Schettini F; Manzionna MM; De Mattia D; Amendola F; Di Bitonto G
Minerva Pediatr; 1990 Dec; 42(12):531-6. PubMed ID: 2087226
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a two-dose measles, mumps, and rubella vaccination schedule in a cohort of college athletes.
Coté TR; Sivertson D; Horan JM; Lindegren ML; Dwyer DM
Public Health Rep; 1993; 108(4):431-5. PubMed ID: 8341775
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
[TBL] [Abstract][Full Text] [Related]
6. Present status of measles and rubella immunization in the United States: a medical progress report.
Krugman S
J Pediatr; 1977 Jan; 90(1):1-12. PubMed ID: 12253
[No Abstract] [Full Text] [Related]
7. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
8. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
Dennehy PH; Saracen CL; Peter G
Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
[TBL] [Abstract][Full Text] [Related]
9. [Field trial of combined measles and rubella live attenuated vaccine].
Takeuchi Y; Togashi T; Sunakawa K; Katou T; Kamiya H; Nakayama T
Kansenshogaku Zasshi; 2002 Jan; 76(1):56-62. PubMed ID: 11852475
[TBL] [Abstract][Full Text] [Related]
10. Decreased measles antibody response after measles-mumps-rubella vaccine in infants with colds.
Krober MS; Stracener CE; Bass JW
JAMA; 1991 Apr; 265(16):2095-6. PubMed ID: 2013930
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
Just M; Berger R; Just V
Dev Biol Stand; 1986; 65():85-8. PubMed ID: 3030863
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
13. [Immune status against measles and rubella among 4 Chilean groups of different ages].
Valenzuela MT; Vega J; Leal I; Vicente M; Young V; Vera L; Fasce R; Ramírez E
Rev Med Chil; 1999 Mar; 127(3):359-65. PubMed ID: 10436723
[TBL] [Abstract][Full Text] [Related]
14. Serological survey for rubella and measles antibodies among first graders.
Schiff GM; Linnemann CC; Shea L; Witte JJ; Ackerman JH; Stapleton L; Elsea WR; Agna M
JAMA; 1974 Jan; 227(1):49-52. PubMed ID: 4859626
[No Abstract] [Full Text] [Related]
15. Prevalence of antibodies against measles, mumps and rubella in Israeli young adults.
Danon YL; Adir Y; Abend I; Zaaide Y; Green MS
Isr J Med Sci; 1992 Oct; 28(10):733-6. PubMed ID: 1399506
[No Abstract] [Full Text] [Related]
16. Comparative evaluation of two combined measles-mumps-rubella vaccines based on AIK and Edmonston- Zagreb strains of measles virus.
Mirchamsy H; Nilforoushan MA; Shafyi A; Razavi J; Ashtiani MP; Youssofi I; Sassani A; Fateh G; Nassiri S
Kitasato Arch Exp Med; 1991 Sep; 64(2-3):141-7. PubMed ID: 1811112
[TBL] [Abstract][Full Text] [Related]
17. The combination measles, mumps, rubella and varicella vaccine in healthy children.
Arbeter AM; Baker L; Starr SE; Plotkin SA
Dev Biol Stand; 1986; 65():89-93. PubMed ID: 3030864
[TBL] [Abstract][Full Text] [Related]
18. [Recognition and immunoprophylaxis of measles and rubella].
Zhang B; Ma L
Zhonghua Er Ke Za Zhi; 2020 Aug; 58(8):698-700. PubMed ID: 32842396
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of measles and rubella vaccines in Oman: a prospective clinical trial.
Kohler KA; Suleiman AJ; Robertson SE; Malankar P; Al-Khusaiby S; Helfand RF; Brown D; Bellini WJ; Sutter RW
J Infect Dis; 2003 May; 187 Suppl 1():S177-85. PubMed ID: 12721911
[TBL] [Abstract][Full Text] [Related]
20. Rubella susceptibility predicts measles susceptibility: implications for postpartum immunization.
Libman MD; Behr MA; Martel N; Ward BJ
Clin Infect Dis; 2000 Dec; 31(6):1501-3. PubMed ID: 11096023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
